Cas9 as a versatile tool for engineering biology

Mali, Prashant, Esvelt, Kevin M, Church, George M·2013·Nature Methods
DOI 10.1038/nmeth.2649

Cited by (999)

Items 301–400 of 999

  1. Cas9-Based Tools for Targeted Genome Editing and Transcriptional Control
    Tao Xu, Yongchao Li, Joy D. Van Nostrand, Zhili He, Jizhong Z. Zhou · 2014 · Applied and Environmental Microbiology
  2. Strategies for Efficient Genome Editing Using CRISPR-Cas9
    Behnom Farboud, Aaron F. Severson, Barbara J Meyer · 2018 · Genetics
  3. CRISPR/Cas9 gene-editing strategies in cardiovascular cells
    Eva Vermersch, Charlène Jouve, Jean‐Sébastien Hulot · 2019 · Cardiovascular Research
  4. CRISPR–Cas system: a powerful tool for genome engineering
    Liang Liu, Xiu-Duo Fan · 2014 · Plant Molecular Biology
  5. Polycistronic tRNA and CRISPR guide-RNA enables highly efficient multiplexed genome engineering in human cells
    Fengping Dong, Kabin Xie, Yueying Chen, Yinong Yang, Yingwei Mao · 2016 · Biochemical and Biophysical Research Communications
  6. Results from the Workshop “Problem Formulation for the Use of Gene Drive in Mosquitoes”
    Andrew Roberts, Paulo Andrade, Fredros O. Okumu, Hector D. Quemada, Moussa Savadogo, Jerome Amir Singh, Stephanie L. James · 2016 · American Journal of Tropical Medicine and Hygiene
  7. CRISPR/Cas9-mediated reversibly immortalized mouse bone marrow stromal stem cells (BMSCs) retain multipotent features of mesenchymal stem cells (MSCs)
    Xue Yu Hu, Li Li, Xinyi Yu, Ruyi Zhang, Shujuan Yan, Zongyue Zeng, Yi Shu, Chen Zhao, Xingye Wu, Jiayan Lei et al. · 2017 · Oncotarget
  8. Gene repression via multiplex gRNA strategy in Y. lipolytica
    Jinlai Zhang, Yang-Zi Peng, Duo Liu, Hong Shu Liu, Yingxiu Cao, Bingzhi Li, Chun Li, Ying‐Jin Yuan · 2018 · Microbial Cell Factories
  9. CRISPR/Cas9-mediated conversion of eGFP- into Gal4-transgenic lines in zebrafish
    Thomas O. Auer, Karine Duroure, Jean‐Paul Concordet, Filippo Del Bene · 2014 · Nature Protocols
  10. Genetic Mapping of Pathogenesis Determinants in Toxoplasma gondii
    Michael S. Behnke, Jitender Prakash Dubey, L. David Sibley · 2016 · Annual Review of Microbiology
  11. Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches
    Emenike K. Onyido, Eloise Sweeney, Abdolrahman Shams Nateri · 2016 · Molecular Cancer
  12. Modeling Late-Onset Sporadic Alzheimer’s Disease through BMI1 Deficiency
    Anthony Flamier, Jida El Hajjar, James Adjaye, Karl J. L. Fernandes, Mohamed Abdouh, Gilbert Bernier · 2018 · Cell Reports
  13. The CRISPR/Cas9 genome editing methodology as a weapon against human viruses.
    Martyn K. White, Wenhui Hu, Kamel Khalili · 2015 · PubMed
  14. CRISPR-Cas-Based Engineering of Probiotics
    Ling Liu, Shimaa Elsayed Helal, Nan Peng · 2023 · BioDesign Research
  15. FlpStop, a tool for conditional gene control in Drosophila
    Yvette E. Fisher, Helen H. Yang, Jesse Isaacman-Beck, Marjorie Xie, Daryl M. Gohl, Thomas R. Clandinin · 2017 · eLife
  16. Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells
    Xiao Wei Zheng, Jia Wan, Ayub Abdulle Nur, Pencheng Dou, Henry J. Mankin, Tang Liu, Zhengxiao Ouyang · 2018 · Cellular Physiology and Biochemistry
  17. Application of Genome Editing in Tomato Breeding: Mechanisms, Advances, and Prospects
    Hymavathi Salava, Sravankumar Thula, Vijee Mohan, Rahul Kumar, Fatemeh Maghuly · 2021 · International Journal of Molecular Sciences
  18. Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9
    Ivailo Simoff, Maria Karlgren, Maria Backlund, Anne-Christine Lindström, Fabienne Zdenka Gaugaz, Pär Matsson, Per Artursson · 2016 · Journal of Pharmaceutical Sciences
  19. A morphospace for synthetic organs and organoids: the possible and the actual
    Aina Ollé-Vila, Salva Duran‐Nebreda, Núria Conde Pueyo, Raúl Montañez, Ricard V. Solé · 2016 · Integrative Biology
  20. CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
    January Salas-McKee, Weimin Kong, Whitney Lynn Gladney, Julie K. Jadlowsky, Gabriela Plesa, Megan M. Suhoski, Joseph A. Fraietta · 2019 · Human Vaccines & Immunotherapeutics
  21. Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
    Xiaoqiang Huang, Dongshan Yang, Jifeng Zhang, Jie Xu, Y. Eugene Chen · 2022 · Cells
  22. CRISPR-Cas9-Based Knockout of the Prion Protein and Its Effect on the Proteome
    Mohadeseh Mehrabian, Brethour Dylan, Sarah MacIsaac, Jin Kyu Kim, C. Geeth Gunawardana, Hansen Wang, Gerold Schmitt‐Ulms · 2014 · PLoS ONE
  23. A versatile reporter system for CRISPR-mediated chromosomal rearrangements
    Yingxiang Li, Angela I. Park, Haiwei Mou, Cansu Colpan, Aizhan Bizhanova, Elliot H. Akama‐Garren, Nik Joshi, Eric A. Hendrickson, David M. Feldser, Hao Yin et al. · 2015 · Genome biology
  24. Biosynthesis of therapeutic natural products using synthetic biology
    Ali Raza Awan, W. M. Shaw, Tom Ellis · 2016 · Advanced Drug Delivery Reviews
  25. Long-term culture and cloning of primary human bronchial basal cells that maintain multipotent differentiation capacity and CFTR channel function
    Jennifer R. Peters‐Hall, Melissa L. Coquelin, Michael J. Torres, Ryan LaRanger, Busola Ruth Alabi, Sei Sho, Josè F. Calva-Moreno, Philip Thomas, Jerry W. Shay · 2018 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  26. Application of CRISPR/Cas9 genome editing to the study and treatment of disease
    Andrea Pellagatti, Hamid Dolatshad, Simona Valletta, Jacqueline Boultwood · 2015 · Archives of Toxicology
  27. Engineered Swine Models of Cancer
    Adrienne L. Watson, Daniel F. Carlson, David A. Largaespada, Perry B. Hackett, Scott C. Fahrenkrug · 2016 · Frontiers in Genetics
  28. Bok regulates mitochondrial fusion and morphology
    Jacqualyn J. Schulman, Laura M. Szczesniak, Eric N. Bunker, Heather A. Nelson, Michael Wm. Roe, Larry E. Wagner, David I. Yule, Richard J.H. Wojcikiewicz · 2019 · Cell Death and Differentiation
  29. Versatile single-step-assembly CRISPR/Cas9 vectors for dual gRNA expression
    Fatwa Adikusuma, Chandran Pfitzner, Paul Quinton Thomas · 2017 · PLoS ONE
  30. Off‐target assessment of CRISPR ‐ C as9 guiding RNA s in human i PS and mouse ES cells
    E‐Pien Tan, Yilong Li, Martin Del Castillo Velasco‐Herrera, Kosuke Yusa, Allan Bradley · 2014 · genesis
  31. PhytoCRISP-Ex: a web-based and stand-alone application to find specific target sequences for CRISPR/CAS editing
    Achal Rastogi, Omer Murik, Chris Bowler, Leı̈la Tirichine · 2016 · BMC Bioinformatics
  32. Recent advances in genome editing and creation of genetically modified pigs
    James R. Butler, Joseph M. Ladowski, Gregory R. Martens, Matthew F. Tector, Alfred Joseph Tector · 2015 · International Journal of Surgery
  33. CRISPR-Cas9, the new kid on the block of fungal molecular biology
    Sven Krappmann · 2016 · Medical Mycology
  34. Retinoic Acid and BMP4 Cooperate with TP63 to alter Chromatin Dynamics during Surface Epithelial Commitment
    Jillian M. Pattison, Sandra P. Melo, Samantha N. Piekos, J. Torkelson, E. Bashkirova, Maxwell R. Mumbach, Charlotte Rajasingh, H. Zhen, Ling-Jie Li, Eric J. Liaw et al. · 2018 · Nature Genetics
  35. Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9
    Gigi C.G. Choi, Peng Zhou, Chaya T. L. Yuen, Becky K.C. Chan, Feng Xu, Siyu Bao, Hoi Yee Chu, Dawn Thean, Kaeling Tan, Koon Ho Wong et al. · 2019 · Nature Methods
  36. Engineering biological systems toward a sustainable bioeconomy
    Mateus Schreiner Garcez Lopes · 2015 · Journal of Industrial Microbiology & Biotechnology
  37. Multiplexed Knockouts in the Model Diatom Phaeodactylum by Episomal Delivery of a Selectable Cas9
    Mark Moosburner, Pardis Gholami, James K. McCarthy, Maxine H. Tan, Vincent A. Bielinski, Andrew Ellis Allen · 2020 · Frontiers in Microbiology
  38. Target-dependent nickase activities of the CRISPR–Cas nucleases Cpf1 and Cas9
    Becky Xu Hua Fu, Justin Smith, Ryan T. Fuchs, Megumu Yamada Mabuchi, Jennifer L. Curcuru, G. Brett Robb, Andrew Z. Fire · 2019 · Nature Microbiology
  39. 3D genome organization in health and disease: emerging opportunities in cancer translational medicine
    Deepak Babu, Melissa J. Fullwood · 2015 · Nucleus
  40. Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
    Richard D. Sokolowski, Shirley Graham, Malcolm F. White · 2014 · Nucleic Acids Research
  41. CRISPR/Cas9 and cancer targets: future possibilities and present challenges
    Martyn K. White, Kamel Khalili · 2016 · Oncotarget
  42. Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists
    Jacqueline Naylor, Arthur T. Suckow, Asha Seth, David J. Baker, Isabelle Sermadiras, Peter Ravn, Rob Howes, Jian‐Liang Li, Mike R. Snaith, Matthew P. Coghlan et al. · 2016 · Biochemical Journal
  43. Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9
    Tao Pan, Xiaorong Wu, Venigalla Basaveswara Rao · 2018 · Science Advances
  44. Cotton germplasm improvement and progress in Pakistan
    Abdul Razzaq, Muhammad Mubashar Zafar, Arfan Ali, Abdul Hafeez, Wajeeha BATOOL, Yùzhēn Shí, Wànkuí Gǒng, Yǒulù Yuán · 2021 · Journal of Cotton Research
  45. CRISPR/Cas9 system: a reliable and facile genome editing tool in modern biology
    Darakhshan Javaid, Shahid Yousuf Ganie, Younis Ahmad Hajam, Mohd Salim Reshi · 2022 · Molecular Biology Reports
  46. Precision genome editing: A small revolution for glycobiology
    Catharina Steentoft, Eric Bennett, Katrine T.-B. G. Schjoldager, Sergey Y. Vakhrushev, Hans Heugh Wandall, Henrik Clausen · 2014 · Glycobiology
  47. Dual-utility NLS drives RNF169-dependent DNA damage responses
    Liwei An, Yiyang Jiang, Howin H. W. Ng, Ellen P.S. Man, Jie Chen, US Khoo, Qingguo Gong, Michael S.Y. Huen · 2017 · Proceedings of the National Academy of Sciences
  48. The pentatricopeptide repeat protein MTSF2 stabilizes a nad1 precursor transcript and defines the 3΄ end of its 5΄-half intron
    Chuande Wang, Fabien Aubé, Noelya Planchard, Martine Quadrado, Céline Dargel-Graffin, Fabien Nogué, Hakim Mireau · 2017 · Nucleic Acids Research
  49. HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure
    Brian Wigdahl · 2014 · MOJ Immunology
  50. Tools and applications in synthetic biology
    I. Cody MacDonald, Tara L. Deans · 2016 · Advanced Drug Delivery Reviews
  51. The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches
    B. Motta, P. Pramstaller, A. Hicks, A. Rossini · 2017 · Stem Cells International
  52. Amplification-free, CRISPR-Cas9 Targeted Enrichment and SMRT Sequencing of Repeat-Expansion Disease Causative Genomic Regions
    Yu‐Chih Tsai, David Greenberg, James Powell, Ida Höijer, Adam Ameur, Maya Strahl, Ethan Ellis, Inger Jonasson, Ricardo Mouro Pinto, Vanessa C. Wheeler et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Alternative polyadenylation in the nervous system: To what lengths will 3′ UTR extensions take us?
    Pedro Miura, Piero Sanfilippo, Sol Shenker, Eric C. Lai · 2014 · BioEssays
  54. CRISPR/Cas9-mediated gene modification and gene knock out in the human-infective parasite Trichomonas vaginalis
    Brian D. Janssen, Yi-Pei Chen, Brenda M. Molgora, Shuqi Wang, Augusto Simões-Barbosa, Patricia J. Johnson · 2018 · Scientific Reports
  55. A new approach to Cas9-based genome editing in Aspergillus niger that is precise, efficient and selectable
    Laure Leynaud-Kieffer, Samuel C. Curran, Irene Kim, Jon Karl Magnuson, John M. Gladden, Scott Baker, Blake Alexander Simmons · 2019 · PLoS ONE
  56. CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
    Weili Yang, Zhuchi Tu, Qiang Sun, Xiao‐Jiang Li · 2016 · Frontiers in Molecular Neuroscience
  57. Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies
    Ling Yu, Shengmao Liu, Shengnan Jia, Feng Xu · 2023 · Biomedicine & Pharmacotherapy
  58. From Loci to Biology
    Sylvia Nürnberg, Hanrui Zhang, Nicholas J. Hand, Robert C. Bauer, Danish Saleheen, Muredach P. Reilly, Daniel James Rader · 2016 · Circulation Research
  59. Application and optimization of CRISPR–Cas9-mediated genome engineering in axolotl (Ambystoma mexicanum)
    Ji‐Feng Fei, Wilson Pak-Kin Lou, Dunja Knapp, Prayag Murawala, Tobias Gerber, Yuka Taniguchi, Sergej Nowoshilow, Shahryar Khattak, Elly Margaret Tanaka · 2018 · Nature Protocols
  60. Current state of research on non‐human primate models of Alzheimer’s disease
    Hong‐Wei Li, Ling Zhang, Chuan Qin · 2019 · Animal Models and Experimental Medicine
  61. Justice in CRISPR/Cas9 Research and Clinical Applications
    Clara Cornelia Hildebrandt, Jonathan Michael Marron · 2018 · The AMA Journal of Ethic
  62. Gold Nanoparticle-Mediated Gene Therapy
    Gayathri A. Kanu, Javad B. M. Parambath, Raed O. Abu Odeh, Ahmed A. M. Mohamed · 2022 · Cancers
  63. Mechanisms of Glucocorticoid-Regulated Gene Transcription
    Sebastiaan H. Meijsing · 2015 · Advances in experimental medicine and biology
  64. From dead leaf, to new life: TAL effectors as tools for synthetic biology
    Orlando de Lange, Andreas Binder, Thomas Lahaye · 2014 · The Plant Journal
  65. Construction of a hybrid β-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo
    Michael B. Tropak, Sayuri Yonekawa, Subha Karumuthil‐Melethil, Patrick Thompson, Warren W. Wakarchuk, Steven J. Gray, Jagdeep Singh Walia, Brian L. Mark, Don J. Mahuran · 2016 · Molecular Therapy — Methods & Clinical Development
  66. Development of CRISPR/Cas9 mediated virus resistance in agriculturally important crops
    Surender Khatodia, Kirti Bhatotia, Narendra Tuteja · 2017 · Bioengineered
  67. Precision gene editing technology and applications in nephrology
    Zachary WareJoncas, Jarryd M. Campbell, Gabriel Martínez‐Gálvez, William A.C. Gendron, Michael A. Barry, Peter C. Harris, Caroline R. Sussman, Stephen Carl Ekker · 2018 · Nature Reviews Nephrology
  68. Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges
    Mahla Chalak, Mahdi Hesaraki, Seyedeh Nasim Mirbahari, Meghdad Yeganeh, Shaghayegh Abdi, Sarah Rajabi, Farhid Hemmatzadeh · 2024 · Life
  69. TALEN-Mediated Knockout of CCR5 Confers Protection Against Infection of Human Immunodeficiency Virus
    Bingjie Shi, Juan Li, Xuanling Shi, Wenxu Jia, Yi Wen, Xiongbing Hu, Fengfeng Zhuang, Jianzhong Xi, Linqi Zhang · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  70. CRISPR knockout rat cytochrome P450 3A1/2 model for advancing drug metabolism and pharmacokinetics research
    Jian Lu, Yanjiao Shao, Xuan Qin, Daozhi Liu, Ang Chen, Dali Li, Mingyao Liu, Xin Wang · 2017 · Scientific Reports
  71. CRISPR/Cas9-Based Genome Editing in Plants
    Yaling Zhang, Xingliang Ma, Xianrong Xie, Yao‐Guang Liu · 2017 · Progress in molecular biology and translational science
  72. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized mice
    Qiaoqiao Xiao, Shuliang Chen, Qiankun Wang, Zhepeng Liu, Shuai Liu, Huan Deng, Wei Hou, Dongcheng Wu, Yong Xiong, Jiafu Li et al. · 2019 · Retrovirology
  73. Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect
    Yu-Fan Chuang, Andrew J. Phipps, Fan‐Li Lin, Valerie F G Hecht, Alex William Hewitt, Peng‐Yuan Wang, Guei‐Sheung Liu · 2021 · Cellular and Molecular Life Sciences
  74. Review: Recent Applications of Gene Editing in Fish Species and Aquatic Medicine
    Anikó Gutási, Sabine Elisabeth Hammer, Mansour El‐Matbouli, Mona Saleh · 2023 · Animals
  75. Intraflagellar transport is deeply integrated in hedgehog signaling
    Thibaut Eguether, Fabrice P. Cordelières, Gregory J. Pazour · 2018 · Molecular Biology of the Cell
  76. A High Excision Potential of TALENs for Integrated DNA of HIV-Based Lentiviral Vector
    Hirotaka Ebina, Yuka Kanemura, Naoko Misawa, Tetsushi Sakuma, Tomoko Kobayashi, Takashi Yamamoto, Yoshio Koyanagi · 2015 · PLoS ONE
  77. Microbial Arsenal of Antiviral Defenses. Part II
    Artem B. Isaev, Olga S. Musharova, Konstantin Severinov · 2021 · Biochemistry (Moscow)
  78. Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases
    Ghizlène Lahlou, Charlotte Calvet, Marie Giorgi, Marie-José Lecomte, Saaïd Safieddine · 2023 · Journal of Clinical Medicine
  79. Cancer mouse models: Past, present and future
    Walid T. Khaled, Pentao Liu · 2014 · Seminars in Cell and Developmental Biology
  80. CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
    Nanyan Zhang, Huiying Zhi, Brian R. Curtis, Sridhar Rao, Chintan Jobaliya, Mortimer Poncz, Deborah L. French, Peter J. Newman · 2015 · Blood
  81. APOBEC3 induces mutations during repair of CRISPR–Cas9-generated DNA breaks
    Liqun Lei, Hongquan Chen, Wei Xue, Bei Yang, Bian Hu, Jia Wei, Lijie Wang, Yiqiang Cui, Wei Li, Jianying Wang et al. · 2017 · Nature Structural & Molecular Biology
  82. A Review of CRISPR-Based Genome Editing: Survival, Evolution and Challenges
    Hafiz Ishfaq Ahmad, Muhammad Jamil Ahmad, Akhtar Rasool Asif, Muhammad Adnan, Muhammad Kashif Iqbal, Khalid Mehmood, Sayyed Aun Muhammad, Ali Akbar Bhuiyan, Abdelmotaleb Elokil, Xiaoyong Du et al. · 2018 · Current Issues in Molecular Biology
  83. CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research
    Dong Wang, Xian-Wang Wang, Xiaochun Peng, Ying Xiang, Shi-Bao Song, Yingying Wang, Lin Chen, Victoria W. Xin, Yan-Ning Lyu, Jiafu Ji et al. · 2018 · Cancer Gene Therapy
  84. Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy
    Wei-Jie Cheng, Ling-Chun Chen, Hsiu‐O Ho, Hong-Liang Lin, Ming‐Thau Sheu · 2018 · International Journal of Nanomedicine
  85. Implementation of a CRISPR-Based System for Gene Regulation in Candida albicans
    Elvira Román, Ioana Coman, Daniel Prieto, Rebeca Alonso‐Monge, Jesús Plá · 2019 · mSphere
  86. CRISPR/Cas system: An emerging technology in stem cell research
    Maria Teresa Valenti, Michela Serena, Luca Dalle Carbonare, Donato Zipeto · 2019 · World Journal of Stem Cells
  87. In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system
    Qian Li, Jing Su, Yi Liu, Xiu Jin, Xiaomei Zhong, Li Mo, Qingnan Wang, Hongxin Deng, Yang Yang · 2021 · Molecular Therapy — Methods & Clinical Development
  88. Multiplexed high-throughput localized electroporation workflow with deep learning–based analysis for cell engineering
    Cesar A. Patino, Nibir Pathak, Prithvijit Mukherjee, So Hyun Park, Gang Bao, Horacio Dante Espinosa · 2022 · Science Advances
  89. CRISPR‐Cas targeted plasmid integration into mammalian cells via non‐homologous end joining
    Ravichandra Bachu, Iñigo Bergareche, Lawrence A. Chasin · 2015 · Biotechnology and Bioengineering
  90. Autophagy in zebrafish
    Máté Varga, Erika Fodor, Tibor Vellai · 2014 · Methods
  91. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome
    Yi Wang, Xianju Liu, Chong Ren, Gan‐Yuan Zhong, Long Yang, Shaohua Li, Zhenchang Liang · 2016 · BMC Plant Biology
  92. ge-CRISPR - An integrated pipeline for the prediction and analysis of sgRNAs genome editing efficiency for CRISPR/Cas system
    Karambir Kaur, Amit Gupta, Akanksha Rajput, Manoj Kumar · 2016 · Scientific Reports
  93. Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing
    Jia Q. Lu, Chen Zhao, Yingze Zhao, Jingfang Zhang, Yue Zhang, Li Chen, Qiyuan Han, Ying Yue, Shuai Peng, Runna Ai et al. · 2017 · Nucleic Acids Research
  94. POLQ plays a key role in the repair of CRISPR /Cas9‐induced double‐stranded breaks in the moss Physcomitrella patens
    Kostlend Mara, Florence Charlot, Anouchka Guyon‐Debast, Didier G. Schaefer, Cécile Collonnier, Mathilde Grelon, Fabien Nogué · 2019 · New Phytologist
  95. Blackjack mutations improve the on-target activities of increased fidelity variants of SpCas9 with 5′ G-extended sgRNAs
    Kulcsár, Péter István, Tálas, András, Tóth, Eszter, Nyeste, Antal, Ligeti, Zoltán, Welker, Zsombor, Welker, Ervin · 2020 · Nature Communications
  96. Advances in yeast genome engineering
    Florian David, Verena Siewers · 2014 · FEMS Yeast Research
  97. Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS
    Manjunath N. Swamy, Haoquan Wu, Premlata Shankar · 2016 · Advanced Drug Delivery Reviews
  98. Insights into maize genome editing via CRISPR/Cas9
    Astha Agarwal, Pranjal Yadava, Krishan Kumar, Ishwar Singh, Tanushri Kaul, A. Pattanayak, Pawan Kumar Agrawal · 2018 · Physiology and Molecular Biology of Plants
  99. Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems
    Han Wu, Qishuai Liu, Hui Shi, Jingke Xie, Quanjun Zhang, Zhen Ouyang, Nan Li, Yi Yang, Zhaoming Liu, Yu Zhao et al. · 2018 · Cellular and Molecular Life Sciences
  100. Challenges and opportunities with CRISPR activation in bacteria for data-driven metabolic engineering
    Jason T. Fontana, David Sparkman-Yager, Jesse G. Zalatan, James M. Carothers · 2020 · Current Opinion in Biotechnology